Ilika updates on trading, Stereax manufacturing, and Goliath product development

Ilika plc (LON:IKA), an independent global expert in solid-state battery technology, has provided updates on trading, Stereax® manufacturing, and Goliath product development, as well as notice of its full year results for the year ended 30 April 2024.

Trading Update for FY24

Unaudited trading for the year ended 30 April 2024 has been in line with management expectations. The Company expects to announce revenues of approximately £2.1m (2023: £0.7m), and an EBITDA loss excluding share-based payments of around £4.5m (2023: EBITDA loss of £7m). Cash and cash equivalents at the period end were £11.9m (30 April 2023: £15.8m).

Operational Update

During the Period, significant progress was made with transferring manufacturing to Cirtec Medical LLC under the licence of Ilika’s thin-film Stereax miniature solid-state batteries for powering medical devices and industrial wireless sensors in specialist environments

Click to view all articles for the EPIC:
Or click to view the full company profile:
Facebook
X
LinkedIn
Ilika plc

More articles like this

Ilika plc

Solid-state batteries driving EV range revolution

Discover the game-changing potential of solid-state batteries for electric vehicles, offering dramatic range boosts, improved safety, and enhanced performance. Join the revolution with Ilika plc.